题名 | Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial |
链接 | https://pubmed.ncbi.nlm.nih.gov/37591292/ |
https://pubmed.ncbi.nlm.nih.gov/37591292/
欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |